Invention Grant
![Thiazolo[5,4-b]pyridine MALT-1 inhibitors](/docs/US/2024-05-28/US11993613B2/abs.jpg.600x600.jpg)
- Patent Title: Thiazolo[5,4-b]pyridine MALT-1 inhibitors
-
Application No.: US18192810Application Date: 2023-03-30
-
Publication No.: US11993613B2Publication Date: 2024-05-28
- Inventor: Puneet Kumar , Anthony Mastracchio , Mark Mills , Andrew William Phillips
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Allisyn Monteleone
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07D513/04
![Thiazolo[5,4-b]pyridine MALT-1 inhibitors](/abs-image/US/2024/05/28/US11993613B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure provides for compounds of the general Formula (I)
wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.
wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.
Public/Granted literature
- US20230312601A1 THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORS Public/Granted day:2023-10-05
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
